Inflammasome-gasdermin axis in bullous pemphigoid
大疱性类天疱疮的炎症小体-gasdermin轴
基本信息
- 批准号:9899921
- 负责人:
- 金额:$ 38.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesAutoantibodiesAutoimmune ProcessAutoimmunityBiological ModelsBiologyBone Marrow TransplantationBullaBullous PemphigoidCASP1 geneCaspaseCell membraneCellular StressCleaved cellComplementCytosolDataDiseaseExtracellular DomainGenesGoalsGrantImmuneImmunoglobulin GIn VitroInflammasomeInflammationInflammation MediatorsInflammatoryInflammatory InfiltrateInflammatory ResponseInjectionsInnate Immune SystemInterleukin-1 betaKnockout MiceLiquid substanceMediatingMolecularMusMutant Strains MiceNatural ImmunityNeutrophil InfiltrationNeutrophilic InfiltratePathogenesisPathogenicityPathologyPathway interactionsPatientsPeptide HydrolasesPositioning AttributeProteinsResearchResistanceRoleSignal PathwaySignal TransductionSkinSurveysTNF geneTestingTherapeuticcaspase 14cytokineeffective therapyexperimental studyin vivoin vivo Modelinnate immune functionkeratinocytemacrophagemouse modelneutrophilpreclinical studysensortranslational impact
项目摘要
Project Summary
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease characterized by autoantibodies
and an inflammatory infiltrate. BP autoantibodies recognize two hemidesmosomal proteins, BP180 and BP230.
Anti-BP180 IgG autoantibodies fix complement and are pathogenic. NC16A, an extracellular domain of BP180,
is the primary target of pathogenic autoantibodies. Elevated proinflammatory cytokines TNF-α and IL-1β are
present in blister fluids and sera of BP patients. However, the roles of these critical inflammatory mediators and
how they are up-regulated in BP remain unknown. Our preliminary results showed that subepidermal blister
formation induced by pathogenic antibodies is dependent on IL-1β, a cytokine whose secretion is uniquely
dependent upon the inflammasome signaling pathway. We further show that specific inflammasome mutant
mice resist the pathology of BP. Therefore, the objective of this proposal is to study the role of
inflammasomes in BP using our BP mouse models. Our central hypothesis for this proposal is that BP
antibodies trigger an inflammasome cascade starting with the NLRP3 inflammasome (Aim 1), that activates
caspase-1 and caspase-14 (Aim 3), culminating in the activation of gasdermin A, which forms the IL-1β
secretion pore (Aim 2). The overall goal of this project is to increase our understanding of the innate immunity
of BP and how it relates to the functions of innate immune system players in inflammation and autoimmunity.
Our preliminary data are promising and strongly support our working hypothesis. Since this proposal integrates
both disease mechanistic and preclinical studies, the findings are expected to have a significant impact on the
treatment of patients with BP and other skin inflammatory disorders. This grant will also have broader
implications to the basic biology of inflammation in the skin. Gasdermin A is a new innate immune gene known
to form a pore in the cell membrane, yet its true function in vivo remains a mystery. Because IL-1β is a potent
and central inflammatory mediator in skin inflammatory disease, these studies with gasdermin A will have
broad impact and will reveal hitherto unimagined aspects of the basic biology of IL-1β secretion from
keratinocytes.
项目摘要
大疱性类天疱疮(BP)是一种以自身抗体为特征的自身免疫性表皮下起泡疾病
和炎症浸润BP自身抗体识别两种半桥粒蛋白,BP 180和BP 230。
抗BP 180 IgG自身抗体固定补体并且是致病的。NC 16 A,BP 180的胞外结构域,
是致病性自身抗体的主要靶点。升高的促炎细胞因子TNF-α和IL-1β是
存在于BP患者的水疱液和血清中。然而,这些关键的炎症介质和
它们在BP中是如何被上调仍不清楚。我们的初步结果表明,表皮下水疱
由致病性抗体诱导的形成依赖于IL-1β,IL-1 β是一种细胞因子,
依赖于炎症体信号通路。我们进一步表明,特定的炎性小体突变体,
小鼠抵抗BP的病理学。因此,本提案的目的是研究
使用我们的BP小鼠模型在BP中发现炎性小体。我们对这一提议的中心假设是,
抗体触发一个炎性体级联反应,从NLRP 3炎性体(Aim 1)开始,
caspase-1和caspase-14(Aim 3),最终激活gasdermin A,形成IL-1β,
分泌孔(Aim 2)。该项目的总体目标是增加我们对先天免疫的了解
以及它如何与先天免疫系统参与者在炎症和自身免疫中的功能相关。
我们的初步数据是有希望的,并强烈支持我们的工作假设。由于这一建议将
无论是疾病机制还是临床前研究,这些发现都有望对
治疗BP和其他皮肤炎性疾病的患者。这项赠款也将有更广泛的
对皮肤炎症的基础生物学的影响。Gasdermin A是一种新的先天免疫基因,
在细胞膜上形成一个小孔,但它在体内的真正功能仍然是一个谜。因为IL-1β是一种有效的
和中枢炎症介质在皮肤炎症性疾病,这些研究与gasdermin A将
广泛的影响,并将揭示迄今无法想象的方面的基本生物学的IL-1β分泌,
角质形成细胞
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhi Liu其他文献
Zhi Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhi Liu', 18)}}的其他基金
Development of a salt-based nanomedicine for non-muscle invasive bladder cancer
开发用于非肌肉浸润性膀胱癌的盐基纳米药物
- 批准号:
10482565 - 财政年份:2022
- 资助金额:
$ 38.99万 - 项目类别:
Development of a radiation-activatable nanoparticle for lung cancer therapy
开发用于肺癌治疗的辐射激活纳米颗粒
- 批准号:
10259278 - 财政年份:2021
- 资助金额:
$ 38.99万 - 项目类别:
Inflammasome-gasdermin axis in bullous pemphigoid
大疱性类天疱疮的炎症小体-gasdermin轴
- 批准号:
10382402 - 财政年份:2018
- 资助金额:
$ 38.99万 - 项目类别:
相似海外基金
Defining the cellular origin of pathogenic autoantibodies
定义致病性自身抗体的细胞起源
- 批准号:
EP/Y031091/1 - 财政年份:2024
- 资助金额:
$ 38.99万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 38.99万 - 项目类别:
Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 38.99万 - 项目类别:
Operating Grants
Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer
肿瘤衍生新表位的自身抗体作为生物标志物和免疫 PET 试剂用于小细胞肺癌的早期检测
- 批准号:
10715807 - 财政年份:2023
- 资助金额:
$ 38.99万 - 项目类别:
Role of pharmacological activity of autoantibodies in ME/CFS
自身抗体药理活性在 ME/CFS 中的作用
- 批准号:
MR/Y003667/1 - 财政年份:2023
- 资助金额:
$ 38.99万 - 项目类别:
Research Grant
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
- 批准号:
10740682 - 财政年份:2023
- 资助金额:
$ 38.99万 - 项目类别:
Pathogenesis of idiopathic nephrotic syndrome: defining the role of B cells and autoantibodies reactive to podocyte proteins
特发性肾病综合征的发病机制:定义 B 细胞和足细胞蛋白反应性自身抗体的作用
- 批准号:
487849 - 财政年份:2023
- 资助金额:
$ 38.99万 - 项目类别:
Operating Grants
Analysis of pathogenesis associated with mutation of complement associated gene and autoantibodies in development/progression of C3 nephropathy.
补体相关基因突变和自身抗体在C3肾病发生/进展中的发病机制分析。
- 批准号:
22K08309 - 财政年份:2022
- 资助金额:
$ 38.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Depleting autoantibodies for the treatment of autoimmunity
消耗自身抗体来治疗自身免疫
- 批准号:
10481071 - 财政年份:2022
- 资助金额:
$ 38.99万 - 项目类别: